KEAP1-dependent synthetic lethality induced by AKT and TXNRD1 inhibitors in lung cancer.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cancer Research

• Publication date

  2013-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-13-0712PMID 23824739PMCID PMC3868367
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A high throughput drug screen for Entamoeba histolytica identifies a new lead and target

  2012cited by this paper
• Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system

  2012cited by this paper
• Repurposing approved and abandoned drugs for the treatment and prevention of cancer through public-private partnership.

  2012cited by this paper
• Comprehensive genomic characterization of squamous cell lung cancers

  2012cited by this paper
• Epigallocatechin-3-gallate prevents TNF-α-induced NF-κB activation thereby upregulating ABCA1 via the Nrf2/Keap1 pathway in macrophage foam cells.

  2012cited by this paper
• A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy

  2012cited by this paper
• The biological activity of auranofin: implications for novel treatment of diseases

  2012cited by this paper
• First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors.

  2011cited by this paper
• Genetic Disruption of KEAP1/CUL3 E3 Ubiquitin Ligase Complex Components is a Key Mechanism of NF-KappaB Pathway Activation in Lung Cancer

  2011cited by this paper
• Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors.

  2011cited by this paper
• Abstract LB-400: STAT3 mediates resistance to MEK inhibitor through microRNA miR-17

  2011cited by this paper
• Loss of Kelch-Like ECH-Associated Protein 1 Function in Prostate Cancer Cells Causes Chemoresistance and Radioresistance and Promotes Tumor Growth

  2010cited by this paper
• Akt and Autophagy Cooperate to Promote Survival of Drug-Resistant Glioma

  2010cited by this paper
• Synthetic Lethal Screen of an EGFR-Centered Network to Improve Targeted Therapies

  2010cited by this paper
• Combination Treatment with MEK and AKT Inhibitors Is More Effective than Each Drug Alone in Human Non-Small Cell Lung Cancer In Vitro and In Vivo

  2010cited by this paper
• Oxidative stress in NSC-741909-induced apoptosis of cancer cells

  2010cited by this paper
• Global downstream pathway analysis reveals a dependence of oncogenic NF-E2-related factor 2 mutation on the mTOR growth signaling pathway.

  2010cited by this paper
• Redox Regulation of Nuclear Post-Translational Modifications During NF-κB Activation

  2009cited by this paper
• p53-dependent inhibition of TrxR1 contributes to the tumor-specific induction of apoptosis by RITA

  2009cited by this paper
• VMA21 deficiency causes an autophagic myopathy by compromising V-ATPase activity and lysosomal acidification.

  2009cited by this paper
• KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta.

  2009cited by this paper
• A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene.

  2009cited by this paper
• Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents

  2008cited by this paper
• Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth.

  2008cited by this paper
• A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor

  2008cited by this paper
• Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in Drosophila.

  2008cited by this paper
• The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation.

  2008cited by this paper
• Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy

  2008cited by this paper
• (-)-Epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells.

  2008cited by this paper
• A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity.

  2007cited by this paper
• Synthetic lethal screen identification of chemosensitizer loci in cancer cells

  2007cited by this paper
• Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells.

  2007cited by this paper
• Thioredoxin signaling as a target for cancer therapy.

  2007cited by this paper
• Dynamic redox control of NF-κB through glutaredoxin-regulated S-glutathionylation of inhibitory κB kinase β

  2006cited by this paper
• Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer

  2006cited by this paper
• Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).

  2006cited by this paper
• BTB Protein Keap1 Targets Antioxidant Transcription Factor Nrf2 for Ubiquitination by the Cullin 3-Roc1 Ligase

  2005cited by this paper
• The thioredoxin-1 inhibitor 1-methylpropyl 2-imidazolyl disulfide (PX-12) decreases vascular permeability in tumor xenografts monitored by dynamic contrast enhanced magnetic resonance imaging.

  2005cited by this paper
• Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery

  2005cited by this paper
• Ferritin Heavy Chain Upregulation by NF- B Inhibits TNF -Induced Apoptosis by Suppressing Reactive Oxygen Species

  2004cited by this paper
• Unique function of the Nrf2-Keap1 pathway in the inducible expression of antioxidant and detoxifying enzymes.

  2004cited by this paper
• Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2

  2004cited by this paper
• Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species.

  2004cited by this paper
• Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation

  2003cited by this paper
• NADPH oxidase activity is essential for Keap1/Nrf2-mediated induction of GCLC in response to 2-indol-3-yl-methylenequinuclidin-3-ols.

  2003cited by this paper
• Phosphorylation of Nrf2 at Ser-40 by Protein Kinase C Regulates Antioxidant Response Element-mediated Transcription*

  2002cited by this paper
• Roles of Nrf2 in activation of antioxidant enzyme genes via antioxidant responsive elements.

  2002cited by this paper
• Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2.

  2000cited by this paper
• An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements.

  1997cited by this paper
• Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models.

  1985cited by this paper
• Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

  1984cited by this paper

• Selenium-containing compounds, selenium nanoparticles and selenoproteins in the prevention and treatment of lung cancer.

  2025cites this paper
• Advances in Synthetic Lethality in Potential Oncology Therapeutic Approaches.

  2025cites this paper
• Combining mechanistic quantitative systems pharmacology modeling and patient-derived organoid testing in MET-aberrant non-small cell lung cancer for high-throughput combination efficacy analysis and personalized treatment design

  2025cites this paper
• Neutrophil in the suppressed immune microenvironment: Critical prognostic factor for lung adenocarcinoma patients with KEAP1 mutation

  2024cites this paper
• Serine synthesis and catabolism in starved lung cancer and primary bronchial epithelial cells

  2024cites this paper
• Auranofin repurposing for lung and pancreatic cancer: low CA12 expression as a marker of sensitivity in patient-derived organoids, with potentiated efficacy by AKT inhibition

  2024cites this paper
• The therapeutic potential of RNA m(6)A in lung cancer

  2024cites this paper
• The Cancer Antioxidant Regulation System in Therapeutic Resistance

  2024cites this paper
• Nestin overexpression reduces the sensitivity of gastric cancer cells to trastuzumab

  2023cites this paper
• Molecular mechanisms and clinical implications of the gold drug auranofin

  2023cites this paper
• Multi-omics analysis identifies distinct subtypes with clinical relevance in lung adenocarcinoma harboring KEAP1/NFE2L2

  2022cites this paper
• Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model

  2022influential citation
• Omics-based identification of an NRF2-related auranofin resistance signature in cancer: Insights into drug repurposing

  2022cites this paper
• USF2-mediated upregulation of TXNRD1 contributes to hepatocellular carcinoma progression by activating Akt/mTOR signaling

  2022cites this paper
• Combined Targeting of the Glutathione and Thioredoxin Antioxidant Systems in Pancreatic Cancer.

  2022cites this paper
• The Role of the Thioredoxin Detoxification System in Cancer Progression and Resistance

  2022cites this paper
• Circular RNAs With Efficacy in Preclinical In Vitro and In Vivo Models of Esophageal Squamous Cell Carcinoma

  2022cites this paper
• Seven ferroptosis-specific expressed genes are considered as potential biomarkers for the diagnosis and treatment of cigarette smoke-induced chronic obstructive pulmonary disease

  2022cites this paper
• Complementing the EGFR dynamic interactome using live-cell proximity labeling

  2022cites this paper
• Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway

  2021cites this paper
• Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness

  2021cites this paper
• Thioredoxin reductase-1 levels are associated with NRF2 pathway activation and tumor recurrence in non-small cell lung cancer.

  2021cites this paper
• Integrative omics analysis identifies subtypes with therapeutic implications in lung adenocarcinoma harboring KEAP1/NFE2L2

  2021cites this paper
• Deep Proteomic Deconvolution of Interferons and HBV Transfection Effects on a Hepatoblastoma Cell Line

  2020cites this paper
• The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies

  2020cites this paper
• Circ0120816 acts as an oncogene of esophageal squamous cell carcinoma by inhibiting miR-1305 and releasing TXNRD1

  2020cites this paper
• microRNA-130b-3p Contained in MSC-Derived EVs Promotes Lung Cancer Progression by Regulating the FOXO3/NFE2L2/TXNRD1 Axis

  2020cites this paper
• Anti-cancer effect of RKIP via modulating autophagy during metastasis

  2020cites this paper
• Antineoplastic effects of auranofin in human pancreatic adenocarcinoma preclinical models

  2019cites this paper
• Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer

  2019cites this paper
• Downregulation of exosomal let-7a-5p in dust exposed- workers contributes to lung cancer development

  2018cites this paper
• Preconditioning by Hydrogen Peroxide Enhances Multiple Properties of Human Decidua Basalis Mesenchymal Stem/Multipotent Stromal Cells

  2018cites this paper
• Bcl-2-dependent synthetic lethal interaction of the IDF-11774 with the V0 subunit C of vacuolar ATPase (ATP6V0C) in colorectal cancer

  2018cites this paper
• Metabolic biomarkers of response to the AKT inhibitor MK-2206 in pre-clinical models of human colorectal and prostate carcinoma

  2018cites this paper
• NRG1 regulates redox homeostasis via NRF2 in papillary thyroid cancer

  2018cites this paper
• Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in Cancer

  2018cites this paper
• PCK1 Downregulation Promotes TXNRD1 Expression and Hepatoma Cell Growth via the Nrf2/Keap1 Pathway

  2018cites this paper
• NRF2 through RPS6 Activation Is Related to Anti-HER2 Drug Resistance in HER2-Amplified Gastric Cancer

  2018cites this paper
• Inhibition of thioredoxin-dependent H2O2 removal sensitizes malignant B-cells to pharmacological ascorbate

  2018cites this paper
• Developing a genetic signature to predict drug response in ovarian cancer

  2017cites this paper
• Apoptosis and Autophagy

  2017cites this paper
• SETD7 is a prognosis predicting factor of breast cancer and regulates redox homeostasis

  2017cites this paper
• Synergistic induction of apoptosis by combination treatment with mesupron and auranofin in human breast cancer cells

  2017cites this paper
• MicroRNA-124 regulates the radiosensitivity of non-small cell lung cancer cells by targeting TXNRD1

  2017cites this paper
• Synergistic induction of apoptosis by combination treatment with mesupron and auranofin in human breast cancer cells

  2017cites this paper
• Methylation of arginine by PRMT1 regulates Nrf2 transcriptional activity during the antioxidative response.

  2016cites this paper
• TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug Auranofin

  2016cites this paper
• A joint modeling approach for uncovering associations between gene expression, bioactivity and chemical structure in early drug discovery to guide lead selection and genomic biomarker development

  2016cites this paper
• Cullin3–KLHL25 ubiquitin ligase targets ACLY for degradation to inhibit lipid synthesis and tumor progression

  2016influential citation
• SoNar, a Highly Responsive NAD+/NADH Sensor, Allows High-Throughput Metabolic Screening of Anti-tumor Agents.

  2015cites this paper
• Enhanced Eryptosis Following Auranofin Exposure

  2015cites this paper
• Auranofin induces apoptosis by ROS-mediated ER stress and mitochondrial dysfunction and displayed synergistic lethality with piperlongumine in gastric cancer

  2015cites this paper
• Selenite in Cancer Therapy

  2015cites this paper
• Molecular Targeted Therapy of Lung Cancer: Challenges and Promises

  2015cites this paper
• Differences in Redox Regulatory Systems in Human Lung and Liver Tumors Suggest Different Avenues for Therapy

  2015cites this paper
• TrkB Promotes Breast Cancer Metastasis via Suppression of Runx3 and Keap1 Expression

  2015cites this paper
• The Overexpression of FEN1 and RAD54B May Act as Independent Prognostic Factors of Lung Adenocarcinoma

  2015cites this paper
• Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells

  2015influential citation
• Inhibition of 19S proteasome-associated deubiquitinases by metal-containing compounds

  2015cites this paper
• RET and other genes: therapeutic targets in lung adenocarcinoma

  2014cites this paper
• Profiling of Phospho-AKT, Phospho-mTOR, Phospho-MAPK and EGFR in Non-small Cell Lung Cancer

  2014cites this paper
• Development of Synthetic Lethality Anticancer Therapeutics

  2014influential citation
• siRNA screening of the kinome identified Aurora A kinase as a therapeutic target gene in cervical cancer

  2014cites this paper
• Role of the Keap1-Nrf2 pathway in cancer.

  2014cites this paper
• The single N-glycan deletion mutant of soluble ErbB3 protein attenuates heregulin β1-induced tumor progression by blocking of the HIF-1 and Nrf2 pathway.

  2014cites this paper
• Anti-oxidative stress response genes: bioinformatic analysis of their expression and relevance in multiple cancers

  2013cites this paper